Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Calling All Blood Donors …Even Older Drugs Are Getting Steep Price Hikes, Study FindsAs Medical Marketing Soars, Is Regulation Needed?Radiation Doses From CT Scans Vary WidelyU.S. Leads Health Care Spending Among Richer Nations, But Gets LessIs Your State a Hotspot for Obesity-Linked Cancers?Health Tip: Choose the Right DoctorFDA Warns Companies on Dangerous, Unapproved Stem Cell TreatmentsMore U.S. Kids Dying From Guns, Car AccidentsRoad Rules on Smartphone Use Are Saving Bikers' Lives, TooAHA: Should Pacemakers, Defibrillators Be Recycled -- and Reused in Others?California Farm Tied to E. coli Outbreak Expands Recall Beyond Romaine LettuceHealth Tip: Use Medical Devices SafelyCalifornia Farm Implicated in Outbreak of E. coli Tied to Romaine LettuceFentanyl Now the No. 1 Opioid OD KillerHospitalizations Rising Among the HomelessElectronic Health Records Bogging Docs DownMore Are Seeking Mental Health Care, But Not Always Those Who Need It MostMillions of Americans Still Breathing Secondhand Smoke: ReportNew Approach to Opioid Crisis: Supervised Heroin Injection Programs?Many Americans Unaware of Promise of Targeted, 'Personalized' Medicine: PollAs Gun Violence Grows, U.S. Life Expectancy DropsMost Americans Lie to Their DoctorsOpioid Crisis, Suicides Driving Decline in U.S. Life Expectancy: CDCWant to Learn CPR? Try an Automated KioskHealth Surrogates Often in Dark About Loved One's WishesRestaurant 'Health Grade' Posters Could Mean Safer DiningSmoking Bans Might Help Nonsmokers' Blood PressureWarmer Winters, More Violent Crimes?Are Food Additives Good or Bad? Consumer Views VaryDrug Studies in Children Often Go Unfinished: StudyFDA Moves to Restrict Flavored E-Cig Sales, Ban Menthol CigarettesAgeism Costs Billions in Health Care DollarsAmerica Is Worried About Antibiotic ResistanceRed Cross Issues Urgent Call for Blood Ahead of the HolidaysUnder Pressure, Juul Withdraws Most Flavored E-Cigs From MarketMany Drugstores Won't Dispense Opioid Antidote as RequiredNew Cholesterol Guidelines Focus on Personalized ApproachAHA: Defibrillators Can Help Kids Survive Cardiac Arrest, TooFDA Will Ban Many Flavored E-CigarettesU.S. Smoking Rates Hit Record LowOnly a Quarter of Opioid Painkillers Taken After Most SurgeriesHome Health-Care Tests: Proceed With CautionFDA Takes on Flatulent CowsWhy Bystanders Are Less Likely to Give CPR to WomenCellphone Radiation Tied to Upped Odds for Cancer -- in RatsHealth Tip: FDA Discusses Possible Risks of Bodybuilding ProductsU.S. Hospitals Making Headway Against InfectionsAfter Mass Shootings, Blood Donations Can Go UnusedLead in Hair Dyes Must Go: FDA
Questions and AnswersLinksBook Reviews
Related Topics

Your Tax Dollars Fund Research on Hundreds of New Meds

HealthDay News
by -- Robert Preidt
Updated: Feb 15th 2018

new article illustration

THURSDAY, Feb. 15, 2018 (HealthDay News) -- The U.S. National Institutes of Health spent more than $100 billion on research that led to 210 new medicines gaining U.S. Food and Drug Administration approval over six years, a new study shows.

Nearly $64 billion of that spending was for the development of 84 first-in-class drugs that use new biological mechanisms or targets.

The study is the first to assess how government funding contributes to the development of new medicines, according to the researchers from Bentley University in Waltham, Mass.

"While basic research can sometimes seem esoteric, our analysis shows that a substantial fraction of NIH-funded, basic research can be directly linked to the medicines first approved in this decade," senior study author Dr. Fred Ledley said in a university news release. He's director of the school's Center for Integration of Science and Industry.

"This data underscores the critical impact of government funding for basic biomedical research on the drug discovery and development process," Ledley said. "Any reduction in this funding would inevitably slow the pipeline of new treatments for diseases that the public so desperately needs."

The study team analyzed more than 2 million published research reports directly linked to the 210 new medicines approved by the FDA between 2010 and 2016, or to their biological targets. Of those reports, 600,000 were connected with NIH-funded research projects that involved more than 200,000 fiscal years of research funding and more than $100 billion in total cost, according to the study.

More than 90 percent of that amount was directly associated with research on the biological targets for drug action, rather than the drugs themselves, and represents basic biomedical research, the study authors explained.

The researchers said this type of basic research is "an enabling step leading to the discovery and development of new medicines for untreatable diseases."

The findings were published online Feb. 12 in the Proceedings of the National Academy of Sciences.

More information

The U.S. Food and Drug Administration has more on the drug development process.